Who are the breast cancer survivors in Malaysia?

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 5, 2012, Pages 2213-2218

  Ibrahim, Nor Idawaty ^a,b   Dahlui, M ^b   Aina, E N ^a,c   Al Sadat, N ^b  

^a MINISTRY OF HEALTH   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c HOSPITAL KUALA LUMPUR   (Malaysia)

Author keywords

Breast cancer; Delayed diagnosis; Ethnic group; Malaysia; Survival; Treatment

Indexed keywords

ADULT; ARTICLE; BREAST TUMOR; CANCER GRADING; CANCER STAGING; COLLOID CARCINOMA; FEMALE; FOLLOW UP; HUMAN; LUNG CARCINOMA; LYMPH NODE; MALAYSIA; MIDDLE AGED; MORTALITY; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; SURVIVOR;

ADENOCARCINOMA, MUCINOUS; ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; MALAYSIA; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; SURVIVORS;

EID: 84872681187     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.5.2213     Document Type: Article

References (29)

1. Al-Naggar RAM, Isa ZM, Shah SA, et al (2009). Eight year survival among breast cancer Malaysian women from University Kebangsaan Malaysia Medical Centre. Asian Pacific journal of cancer prevention. Asian Pac J Cancer Prev, 10, 1075-8.
2. Banarjee M, George J, Song EY, Roy AHW (2003). Tree-based model for breast cancer prognostication. J Surg Oncol, 83, 167-72.
3. Campbell JB (2002). Breast cancer-race, ethnicity, and survival: a literature review. Breast cancer research and treatment. Breast Cancer Res Treat, 74, 187-92.
4. Carter CL, Allen C, HD (1989). Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases. Cancer, 63, 181-7.
5. Ferlay J, Shin HR, Bray F, et al (2008). Cancer Incidence and Mortality Worldwide (p. Version 1.2 IARC Cancer Base No.10 Lyon).
6. Gebauer G, Fehm T, Lang N, Jäger W (2002). Tumour size, axillary lymph node status and steroid receptor expression in breast cancer. Prognostic relevance 5 years after surgery. Breast cancer research and treatment. Breast Cancer Res Treat, 75, 167-73.
7. Golledge J, Wiggins JE, Callam MJ (2000). Age related variation in the treatment and outcomes of patients with breast carcinoma. Cancer, 88, 369-74.
8. Gordon NH, Crowe JP, Brumberg DJ, BN (1992). Socio-economic factors and race in breast cancer recurrence and survival. Am J Epidemiol, 135, 609-18.
9. Hawkins RA, Tesdale AL, K M (1996). Prospective evaluation of prognostic factors in operable breast cancer. Br J Cancer, 74, 1469-78.
10. Hebert JR, Ghumare SS, G P (2006). Stages at diagnosis and relative differences in breast and prostate cancer incidence in India: comparison with the United States. Asian Pac J Cancer Prev, 7, 547-55.
11. Hisham AN, Yip CH (2004). Overview of Breast Cancer in Malaysian Women Asian journal of surgery/Asian Surgical Association. Asian J Surg, 27, 130-3.
12. Jatoi I, Becher H, L C (2003). Widening disparity in survival between white and African-American patients with breast carcinoma treated in the US Department of Defense healthcare system. Cancer, 98, 894-9.
13. Jemal A, Bray F, Ferlay J (2011). Global Cancer Statistics. World, 61, 69-90.
14. Knight WA, Livingston RB, Gregory EJ, M W (1977). Estrogen receptor as an independent prognostic factor for early recurrence in bresat cancer. Cancer Res, 37, 4669-71.
15. Leong BD, Chuah JA, Kumar VM (2007). Breast cancer in Sabah, Malaysia: a two prospective study. APJCP, 8, 525-9.
16. Lim GCC, Rampal S (2008). Cancer Incidence in Peninsular Malaysia, 2003-2005. National Cancer Registry. Kuala Lumpur.
17. Lim, Gerard, Yahaya, H (2004). Second Report of the National Cancer Registry. Cancer Incidence in Malaysia 2003.National Cancer Registry, Kuala Lumpur (pp. 1-141).
18. May DS, Lee NC, Richardson LC, Giustozzi AG (2000). Mammography and breast cancer detection by race and Hispanic ethnicity: results from a national program (United States). Cancer Causes Control, 11, 697-705.
19. Mohd Taib NA, Akmal MN, Mohamed I (2011). Improvement in survival of breast cancer patients - trends over two time periods in a single institution in an Asia Pacific country, Malaysia. Asian Pac J Cancer Prev, 12, 345-49.
20. Mohd Taib NA, Yip CH (2008). Survival analysis of Malaysian women with breast cancer: results from the University of Malaya Medical Centre. Asian Pac J Cancer Prev, 9, 197-202.
21. Ong TA (2003). Short-term survival in breast cancer: the experience of the University of Malaya Medical Centre. Asian journal of surgery. Asian Surg Assoc, 26, 169-75.
22. Pathy NB, Yip CH, Taib NA, et al (2011). Breast cancer in a multi-ethnic Asian setting: results from the Singapore-Malaysia hospital-based breast cancer registry. Breast, 20, 75-80.
23. Potosky AL, Merill RM, Riley GF, et al (1997). Breast Cancer Survival and Treatment in Health Maintenance Organization and Fee for Services settings. J Natl Cancer Inst, 89, 1683-91.
24. Ragland KE, Selvin S (1991). Black-White differences in stage specific cancer survival: analysis of seven sites. Am J Epidemiology, 133, 672-82.
25. Rezaianzadeh A, Peacock J, Reidpath D, et al (2009). Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran. BMC Cancer, 9, 168.
26. Saez RA, McGuire WL (1989). Prognostic factors in breast cancer. Semin Surg Oncol, 5, 105-10.
27. Shavers VL (2002). Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst, 94, 334-57.
28. Taib NA, Yip CH, Mohamed I, Ng CJ (2007). Breast cancer in Malaysia: are our women getting the right message? 10 year-experience in a single institution in Malaysia. Asian Pac J Cancer Prev, 8, 141-5.
29. Tan EY, ONE AUTHOR, ONE AUTHOR, et al (2005). Locally advanced and metastatic breast cancer in a tertiary hospital. Ann Acad Med Singapore, 34, 595-601.